-AD-
-AD-
HomeNewsVenom Expands into India with Dual Listings on WazirX and CoinDCX

Venom Expands into India with Dual Listings on WazirX and CoinDCX

- Advertisement -

Global, Global, July 4th, 2024, Chainwire

Venom Foundation is pleased to announce a major milestone in its global expansion strategy: the listing of its native token, $VENOM, on two of India’s leading cryptocurrency exchanges, WazirX and CoinDCX. This pivotal move grants Venom access to a massive user base in the world’s most populous country, further driving the adoption and visibility of $VENOM.

“We are thrilled to announce the listing of $VENOM on WazirX and CoinDCX. This strategic move into the Indian market, with access to over 30 million users, marks a significant milestone for Venom. It underscores our commitment to fostering innovation and adoption in the blockchain space, paving the way for greater engagement and growth in one of the world’s most dynamic crypto markets.” – Louis Tsu, CEO of Venom Foundation

Rajagopal Menon, VP of Marketing at WazirX, said, “VENOM network has already checked several boxes such as addressing scalability and transaction issues in the crypto ecosystem. It has a diverse range of partnerships and its ongoing expansion showcases its popularity and burgeoning user base. WazirX is excited to give users the opportunity to trade this token.”

India: A Key Market for Venom

As the global cryptocurrency landscape evolves, India has emerged as a vital hub for blockchain and crypto. With its tech-savvy population and rapidly growing crypto community, India represents a monumental opportunity for Venom to expand its reach and drive adoption.

Listings on WazirX and CoinDCX

WazirX: As India’s largest cryptocurrency exchange, WazirX serves over 16 million users. $VENOM is now available for trading in USDT and INR pairs.

CoinDCX: CoinDCX, another major player in the Indian market, boasts over 14 million users. $VENOM is also available for trading in USDT and INR pairs.

Key Highlights

Vast User Reach: The combined user base of over 30 million on WazirX and CoinDCX offers unparalleled exposure for $VENOM in India.

Market Expansion: These listings mark a crucial milestone in Venom’s expansion strategy, highlighting the explosive growth and adoption of $VENOM in one of the world’s fastest-growing crypto markets.

Enhanced Accessibility: Indian users now have streamlined access to trade $VENOM in their local currency, fostering greater adoption and engagement.

Conclusion

The listings of $VENOM on WazirX and CoinDCX are pivotal steps in Venom’s strategy to enhance its global reach and liquidity. These listings align with the Venom Foundation goal of increasing adoption and expanding it’s presence in the global crypto landscape.

About Venom

Venom is a cutting-edge layer-0 and layer-1 network, seamlessly integrating with other independent networks through innovative Mesh technology. Anchored by a masterchain for overall state and consensus management, Venom supports unlimited autonomous workchains for user accounts, smart contracts, and dApps. Mesh technology optimizes inter-chain communication, ensuring speed and scalability. With rapid finality, comprehensive security, stability, and user-friendly interfaces, Venom is ideal for hosting CBDCs and large-scale platforms. Learn more at https://venom.foundation/

Contact

Venom Foundation
media@venom.network

ETHNews: This publication is sponsored. ETHNews does not endorse and is not responsible for or liable for any content, accuracy, quality, advertising, products, or other materials on this page. Readers should conduct their own research before taking any actions related to the company. ETHNews is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods, or services mentioned in the press release.
This article is provided for informational purposes only and is not intended as investment advice. The content does not constitute a recommendation to buy, sell, or hold any securities or financial instruments. Readers should conduct their own research and consult with financial advisors before making investment decisions. The information presented may not be current and could become outdated.
By accessing and reading this article, you acknowledge and agree to the above disclosure and disclaimer.
RELATED ARTICLES

LATEST ARTICLES